Natural Whole Plant Medicines
Vir Pharma holds both import and manufacturing licences for the distribution of medical cannabis in Australia.
Our whole plant based approach allows us to develop medicines of the highest quality for TGA approval. Through tissue culture propagation our expert team is able to produce high health cannabis plant clones, free from pests and diseases. Our breeders are developing new strains that deliver greater yield, phenotyping, non-primary cannabinoids and specific chemotypes to provide whole plant extracts, preserving the balance of the medicines we create.
We’re currently working to develop a locally cultivated whole plant medical cannabis product which will be available for clinical trials in 2019.
Vir Pharma is the exclusive import and distribution partner of Whistler Medical Marijuana Corporation (WMMC) in Australia. WMMC is Canada's first licensed producer of organic cannabis medicines and their entire product line is 100% certified organic.
Accessing Our Products
WMMC products are only available through the Therapeutic Goods Administration (TGA) Special Access Scheme (Cat B) or through the Authorised Prescriber scheme. Vir Pharma can not provide medical cannabis products to individuals under any circumstances.
Physicians will need to submit an application under the Special Access Scheme or the Authorised Prescriber Scheme. Further information on the application process can be found on the TGA website. If you're a physician and need help with the application process, get in touch and we can help.
Product Side Effects
Like all prescription medicines, patients can experience possible side effects when using medical cannabis products. It’s important to speak to your doctor about the suitability of medical cannabis for the treatment of your specific condition. For more information visit our FAQ page.